Publication: Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey.
Loading...
Identifiers
Date
2022-09
Authors
Hoste, Levi
Soriano-Arandes, Antoni
Buddingh, Emilie Pauline
Whittaker, Elizabeth
Belot, Alexandre
Ulloa-Gutierrez, Rolando
Olbrich, Peter
Haerynck, Filomeen
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier Inc.
Metrics
Export
Abstract
The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.
Description
MeSH Terms
COVID-19
Child
Humans
SARS-CoV-2
Surveys and Questionnaires
Systemic Inflammatory Response Syndrome
Vaccination
Child
Humans
SARS-CoV-2
Surveys and Questionnaires
Systemic Inflammatory Response Syndrome
Vaccination
DeCS Terms
Síndrome de respuesta inflamatoria sistémica
SARS-CoV-2
Pandemias
Síndrome de Guillain-Barré
Vacuna BNT162
Insuficiencia respiratoria
Enfermedad aguda
SARS-CoV-2
Pandemias
Síndrome de Guillain-Barré
Vacuna BNT162
Insuficiencia respiratoria
Enfermedad aguda
CIE Terms
Keywords
COVID-19, MIS-C, SARS-CoV-2, adverse events, vaccination
Citation
Hoste L; MIS-C researchers; Soriano-Arandes A, Buddingh EP, Whittaker E, Belot A, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey. J Pediatr. 2022 Sep;248:114-118.